The risk of developing breast cancer is linked to many environmental exposures. Certain lifestyle factors, such as not exercising and smoking, are also linked to increased risk. Women have a higher chance of developing breast cancer if their family has breast cancer (particularly, an extended family member). Genetic factors can increase the chances of breast cancer as well. Women with BRCA mutations have a 2- to 3-fold increased risk of developing breast cancer, compared to those without the family history for breast cancer. There are currently no cures for breast cancer and treatment often consists of surgery, chemotherapy and/or radiation therapy.
The American Cancer Society estimates there will be a total of nearly 1 million new diagnoses of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) in 2016. The 5-year survival rate for breast cancer patients is 91.7%. women die of breast cancer at a rate of over 1 in 10 every year in the United States.
The majority of women with [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) have access to cancer treatment. The most frequent treatment for women with cancer is surgery. Chemotherapy is also frequently used to treat breast cancer.
Findings from a recent study of the present study indicated that the use of the WHOBASQ in Iranian women presenting for breast cancer screening can have great potential in detecting women in early stages of breast cancer and improving their prognosis by facilitating diagnosis for early stage breast cancer and reducing the risk of breast cancer, and in particular, a decrease in the risk of developing early stage breast cancer and improving survival rates.
It is common for patients with sporadic breast cancer to be offered a palliative treatment such as mastectomy or chemotherapy. Survival time is improved by a good prognosis of the disease and the ability of patients to accept palliative treatment to increase quality of life.
Breast cancer is the most common cancer that is diagnosed in women in the UK. About 75% of all sufferers develop [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) before the age of 50. It is a life-threatening disease in its early stages – women are advised to undergo routine screening of their breast health in order to spot cancer as early as possible.\n
Almost any cancer can be cured with an excision of the tumor. The most common of its conditions, like a mammary gland tumor, is commonly resolved by an excision. The only condition under which the resection is seldom successful, and there may be a danger to the person, is to remove the nipple as part of the surgery (called a lumpectomy) for the treatment of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer). The treatment of breast cancer with the resections and lumpectomies is a surgery in which the surgeon removes the whole tumor instead of simply cutting it away with a knife. A doctor removes a part of the breast that may contain more cancer, and then performs an additional surgery to reconnect everything afterwards.
Breast cancer surgery is one of the most challenging procedures because it requires very precise surgical judgment. Breast cancer patients' quality of life and cosmesis are more important to them than to their surgeons. Patient education and understanding of the procedure are crucial to the success of the surgery. The postoperative patient will be more likely to have pain after the surgery than before it. Postoperative pain can be controlled and managed with various analgesic methods. Patients should expect that pain during the first few days after the surgery will be very painful. Complications following breast cancer surgery include hematoma, seroma, infection, lymphedema, wound dehiscence, scar contracture, and nerve injury.
Breast cancer is caused by environmental, hereditary, and lifestyle factors and their combined influence. Genetic causes include hereditary breast-cancer predisposition (see BRCA2 and BRCA1), and women who have the BRCA1 gene but not BRCA2 are at an increased risk, especially if they are also exposed to polycyclic aromatic hydrocarbons. Other risks include an increased likelihood of breast cancer among those who smoke, and the use of oral contraceptives in women younger than age 40.
The chance of a woman developing breast cancer is 7% by age 30, 18% by 50 and 50% by age 60. The number of women who develop breast cancer by age 75 is approximately the same for both men and women: 2.3% for men and 2.5% for women. More specifically, the chance of developing breast cancer is 3.9% by age 35, 9.2% by 40, 23.3% by 45, 56.4% by 50 and 75% by age 75.
These participants understood what they were going to be part of and they were able to make well informed decisions about their participation. To address concerns about the impact of adjuvant therapy on quality of life, clinicians need to be more aware of these aspects when communicating with trial participants. Trials need to be designed to allow for the use of these aspects of people's lives to be included in measurement instruments, thereby allowing for a better understanding of the effect of treatment on quality of life.
Once the MDs have assessed every aspect of the tumor the patient is scheduled for surgery. It’s important to choose someone who can have an operation to remove the tumor without too much risk of compromising your healing or even causing bleeding. It’s like you go in for surgery to have your knee replaced, but the surgeon decides to place the implant in your gluteus maximus muscle instead of in your knee joint. Or if you were having a hysterectomy, but then chose to have it all done together as an extra procedure, the doctor decides she wants to shave you down with an instrument instead of cutting you open. Then in the case of surgery it’s more of the same.